Status:
UNKNOWN
Saphenous Nerve Block for Partial Meniscectomy
Lead Sponsor:
Rothman Institute Orthopaedics
Conditions:
Pain, Joint
Pain, Procedural
Eligibility:
All Genders
18+ years
Phase:
PHASE3
Brief Summary
Partial meniscectomy and meniscus repair are two of the most common orthopedic surgery procedures. As these procedures are being increasingly performed in ambulatory surgical centers, there has been a...
Eligibility Criteria
Inclusion
- Age ≥ 18
- Scheduled for arthroscopic meniscectomy or meniscus repair
Exclusion
- Multiple-ligament injury
- Primary ACL reconstruction or ACL revision reconstruction
- Articular cartilage restoration surgery
- Evidence of microfracture
- History of allergy to local anesthetics
- Pre-existing saphenous neuropathy
- Unable to be prescribed opioids due to allergy or other reason
Key Trial Info
Start Date :
January 25 2021
Trial Type :
INTERVENTIONAL
Allocation :
ACTUAL
End Date :
January 25 2022
Estimated Enrollment :
160 Patients enrolled
Trial Details
Trial ID
NCT04717609
Start Date
January 25 2021
End Date
January 25 2022
Last Update
January 22 2021
Active Locations (1)
Enter a location and click search to find clinical trials sorted by distance.
1
Rothman Orthopaedic Institute
Philadelphia, Pennsylvania, United States, 19107